Fulcrum Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript
Good morning, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, I'm one of the biotech analysts here at Morgan Stanley. Pleased to have Fulcrum with us for the next session.
Just briefly before we get started, I need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures.
So with that, out of the way, we can get going. Happy to have Bryan Stuart, the CEO of Fulcrum with us.
Bryan, maybe just to kick it off before we get into the program, just talk about the platform at Fulcrum and how you're generating targets there?
Yes, absolutely. So thanks, everyone, for joining us. So Fulcrum started about 6 years ago, really around the idea of looking to find disease-modifying therapies
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |